Enterprise Value
379.1M
Cash
227.3M
Avg Qtr Burn
-9.08M
Short % of Float
11.41%
Insider Ownership
1.45%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Nomlabofusp (CTI-1601) Details Rare genetic disease, Rare diseases, Friedreich’s Ataxia | Phase 2 Data readout |